ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
57,674.57
-4.82%
S&P 500
5,035.69
0.00%
Dow Jones
37,815.92
0.00%
US Dollar vs Yen
157.771
0.03%
Brent Oil
85.065
-0.97%
Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. 23andMe Holding Company (ME)

  7. 23andMe Holding Company (ME) ニュース

ME 23andMe Holding Company

0.5096
0.0074 (1.47%)
プレマーケット
最終更新日： 22:06:49
15分遅延
名称 銘柄コード 市場 種別
23andMe Holding Company ME NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
Upgrade Icon
0.0074 1.47% 0.5096 22:06:49
始値 安値 高値 終値 前日終値
0.5022
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/5/0100:00BWPotter Handy Law Firm Represents Nearly 5,000 Clients in..
2024/4/2505:05GLOBE23andMe to Present Preliminary Efficacy and Biomarker Data..
2024/4/1821:00GLOBE23andMe announces CEO’s intention to pursue a potential..
2024/4/0605:05GLOBE23andMe to Present Data on Two Clinical Stage..
2024/3/2020:30GLOBE23andMe Initiates Phase 1 Clinical Trial for its Dual..
2024/3/1921:00GLOBE23andMe Launches New Feature Connecting Customers to..
2024/3/0621:30GLOBE23andMe Launches New Genetic Reports on Common Forms of..
2024/3/0606:30GLOBE23andMe Announces Three Presentations from Clinical-Stage..
2024/2/2206:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0806:07EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/2/0806:03EDGAR2Form 8-K - Current report
2024/2/0806:01GLOBE23andMe Reports Third Quarter Fiscal 2024 Financial Results
2024/2/0621:00BWMoneta Gold and Nighthawk Gold Complete At-Market Merger to..
2024/1/3121:50EDGAR2Form 8-K - Current report
2024/1/3112:12GLOBE23andMe Launches Month-Long Initiative to Amplify ARRAY’s..
2024/1/3107:00BWNighthawk Gold Obtains Final Court Order for the Proposed..
2024/1/2506:05GLOBE23andMe to Report FY2024 Third Quarter Financial Results
2024/1/2222:00BWMoneta Gold and Nighthawk Gold Announce the Proposed..
2024/1/0821:45EDGAR2Form 8-K - Current report
2023/12/1922:00GLOBE23andMe announces further expansion of 23ME-00610 Phase 1/2a..
2023/12/0206:06EDGAR2Form 8-K/A - Current report: [Amend]
2023/11/2821:15BWNighthawk and Moneta Announce At-Market Merger to Create a..
2023/11/2206:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/2206:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/1406:06EDGAR2Form 8-K - Current report
2023/11/0906:29EDGAR2Form 8-K - Current report
2023/11/0906:05GLOBE23andMe Reports Second Quarter Fiscal 2024 Financial Results
2023/11/0722:00GLOBE23andMe Launches Total Health™, its..
2023/11/0622:15EDGAR2Form 8-K - Current report
2023/11/0622:00GLOBE23andMe Announces Updated Safety and Preliminary Efficacy..
2023/10/3121:00GLOBE23andMe Launches Health Action Plan to Provide Personalized..
2023/10/3105:05EDGAR2Form 8-K - Current report
2023/10/3021:00GLOBE23andMe Announces Collaboration Extension with a New Data..
2023/10/2805:06EDGAR2Form 8-K - Current report
2023/10/2605:05GLOBE23andMe to Report FY2024 Second Quarter Financial Results
2023/10/1105:17EDGAR2Form 8-K - Current report
2023/9/2805:05GLOBE23andMe Announces Poster Presentations on 23ME-00610, an..
2023/9/2005:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/9/2005:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/9/2005:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/9/2005:06EDGAR2Form 8-K - Current report
2023/9/1605:06EDGAR2Form S-8 - Securities to be offered to employees in employee..
2023/9/1420:00GLOBE23andMe and Sickle Cell 101 Collaborate to Expand Sickle..
2023/9/1205:06EDGAR2Form 8-K - Current report
2023/9/0905:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/9/0905:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/9/0706:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/9/0607:30EDGAR2Form 144 - Report of proposed sale of securities
2023/9/0106:28GLOBE23andMe Granted New FDA Clearance to Report Additional BRCA..
2023/8/2305:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..

最近閲覧した銘柄

NASDAQ
ME
23andMe
Delayed Upgrade Clock
ADVFN Logo

日本
会社情報
ビジネス
人気
アプリを入手

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有